The Bone Matrix
Strength of Cement
Bonding and Strength of Aggregate
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Masaki Kamimura1, Jiro Tamura, Shuichi Shinzato
1Department of Orthopaedic Surgery, Faculty of Medicine, Kyoto University, Kawahara-cho 54, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
This study compared two types of bioactive bone cements with standard PMMA cement. The researchers measured how strongly each cement adhered to bone in rabbits over time. They found that bioactive cements showed significantly higher strength than PMMA as early as 4 weeks after implantation. By 16 weeks, one of the bioactive cements reached a maximum strength of 12.39 kgf. Histological analysis showed direct bone-cement contact with no intervening layer for bioactive cements, while PMMA had fibrous tissue at the interface. These findings suggest that bioactive PMMA cements may offer better adhesion and could be a promising alternative in orthopedic surgery.
Area of Science:
Background:
Bone cement adhesion remains a critical challenge in orthopedic surgery. Standard polymethylmethacrylate (PMMA) cements often fail due to poor interfacial strength. Prior research has shown that PMMA lacks long-term bonding with bone tissue. This limitation has driven interest in bioactive alternatives. However, the exact mechanisms of adhesion improvement remain unclear. No prior work had resolved how specific filler materials influence interfacial strength over time. This gap motivated the investigation into bioactive glass and ceramic fillers. The study aimed to address this knowledge gap through novel experimental methods.
Purpose Of The Study:
The study aimed to evaluate the interfacial tensile strength of two bioactive PMMA-based cements compared to conventional PMMA. The specific problem addressed was the lack of durable bonding between standard PMMA and bone. The motivation stemmed from clinical needs for longer-lasting implants. The researchers sought to determine if bioactive fillers could enhance adhesion. They focused on comparing the performance of GBC and AWC with PMMA over time. The goal was to assess whether these cements could form stronger interfaces. The study's design allowed for longitudinal measurement of tensile strength. The results could inform the development of improved orthopedic materials.
Main Methods:
The study used a novel in situ polymerization method to assess interfacial strength. Two types of bioactive cements—GBC and AWC—were compared with PMMA. The cements were placed in frames attached to rabbit tibial metaphyseal cortex. The frames ensured controlled cement-bone contact during polymerization. Tensile strength was measured at 4, 8, and 16 weeks post-implantation. Load detachment data were collected using standardized mechanical testing. Histological analysis was performed to examine interface morphology. The experimental setup allowed for direct comparison of adhesion properties.
Main Results:
The interfacial tensile strength of GBC and AWC exceeded PMMA from 4 weeks post-implantation. At 16 weeks, GBC reached a maximum of 12.39 ± 1.79 kgf. AWC also showed significantly higher strength than PMMA at all time points. Both bioactive cements demonstrated increasing strength over time. Histology revealed direct bone-cement contact with no intervening layer for GBC and AWC. In contrast, PMMA showed fibrous tissue at the interface. The absence of intervening layers suggests stronger bonding. These findings indicate improved adhesion with bioactive fillers.
Conclusions:
The authors propose that bioactive PMMA cements have higher interfacial strength than conventional PMMA. The results suggest that bioactive fillers may enhance adhesion at the bone-cement interface. The absence of fibrous tissue supports stronger bonding with bone. The increase in tensile strength over time indicates progressive adhesion. The study implies that bioactive cements could serve as a promising alternative. The findings suggest potential clinical applications in orthopedic surgery. The results align with the hypothesis that bioactive materials improve adhesion. The study contributes to understanding interfacial mechanics in bone cements.
The study found that bioactive cements showed significantly higher interfacial tensile strength than PMMA at 4 weeks, reaching 12.39 ± 1.79 kgf for GBC at 16 weeks.
The study tested bioactive glass beads (GBC) and apatite-wollastonite-containing glass-ceramic powder (AWC) as fillers.
The rabbit tibial metaphyseal cortex provided a standardized model for measuring interfacial strength in a controlled biological environment.
Histology confirmed direct bone-cement contact for bioactive cements and fibrous tissue formation with PMMA, supporting the tensile strength findings.
Strength was measured by determining the load required to detach the cement from the bone at 4, 8, and 16 weeks post-implantation.
The authors suggest that bioactive PMMA cements may serve as a promising alternative to conventional PMMA due to improved interfacial adhesion.